trending Market Intelligence /marketintelligence/en/news-insights/trending/B93meqRbuhShSzQudTYsJw2 content esgSubNav
In This List

House Oversight chair, longtime drug industry critic Elijah Cummings dies

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


House Oversight chair, longtime drug industry critic Elijah Cummings dies

Rep. Elijah Cummings, D-Md., chairman of the House Oversight and Reform Committee, died early Oct. 17 at Johns Hopkins Hospital in Baltimore from complications related to longstanding health issues, his office said. He was 68.

SNL ImageRep. Elijah Cummings
Source: AP Photo

Cummings had long pressed his colleagues on Capitol Hill to adopt legislation aimed at lowering drug prices and had convened a number of hearings on the matter.

The Maryland congressman had launched a number of investigations into drugmakers.

In January, he opened an investigation into the pricing practices of a dozen of the largest biopharmaceutical manufacturers involving medicines to treat multiple diseases.

He most recently accused Teva Pharmaceutical Industries Ltd., Mylan NV and Heritage Pharmaceuticals Inc. of stonewalling his probe into price-fixing.

In July, he said he would bring drugmakers before his panel this fall to explain the companies' prices.

Cummings also led a number of investigations into President Donald Trump and the role his family members played in his administration.